FoxM1 has been found with aberrantly high expression in almost all kinds of cancers, including lung cancer, glioblastoma, prostate cancer, basal cell carcinoma, hepatocellular carcinoma, breast cancer and primary pancreatic cancer.2,3 Our analysis in Oncomine and tissue arrays also showed that the FoxM1 expression is abnormal in hepatocellular carcinoma, gastric cancer and colorectal cancer (Fig. 1b, d). Here, FOXM1 is linked to prostate carcinoma.